Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Metabolic toxin" is not a single molecule or defined therapeutic target but rather refers broadly to harmful substances produced during normal metabolic processes, including byproducts like ammonia, urea, carbon dioxide, nitrates/nitrites—substances that must be efficiently processed and eliminated by the body’s detoxification systems. Inadequate clearance due to nutritional imbalances or organ dysfunction can lead these compounds to accumulate at toxic levels. The term also encompasses incompletely digested substances described as "ama" in Ayurveda. Metabolic toxins are implicated in diverse health issues ranging from neurocognitive impairment (such as toxic metabolic encephalopathy) through cardiovascular disease and immune dysfunction. They are not considered druggable targets themselves but represent a class of endogenous challenges managed by physiological pathways involving enzymes like cytochrome P450s and glutathione-S-transferases. In summary: “Metabolic toxin” is an umbrella term for various endogenous harmful metabolites rather than a specific molecular entity suitable for structured drug targeting. This entry does not correspond to any canonical therapeutic target, such as an enzyme/receptor/transporter/protein/gene. It describes a broad category rather than an individual molecule with standardized nomenclature suitable for structured databases.
Not applicable as a direct target. However, mechanisms relevant to reducing metabolic toxins include: Enhancement of phase I/II/III detoxification enzymes (e.g., cytochrome P450s, glutathione-S-transferases). Conjugation reactions making toxins more water-soluble for excretion via urine or bile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metabolic toxin.